Artivion, Inc.
AORT
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. Itā¦ read more
Healthcare
Medical Devices
32 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$44.87
Price-5.54%
-$2.63
1Y
Price
Market Cap
$2.117b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+14.4%
EBITDA Margin+1.2%
Net Profit Margin-6.2%
Free Cash Flow MarginRevenue
$405.037m
+4.3%
1y CAGR+8.9%
3y CAGR+8.0%
5y CAGREarnings
-$17.931m
-34.2%
1y CAGR-12.5%
3y CAGR-16.8%
5y CAGREPS
-$0.43
-34.4%
1y CAGR-11.1%
3y CAGR-14.9%
5y CAGRBook Value
$419.902m
$838.387m
Assets$418.485m
Liabilities$8.794m
DebtDebt to Assets
1.1%
0.2x
Debt to EBITDAFree Cash Flow
-$11.077m
-200.3%
1y CAGR-10.5%
3y CAGR-8.2%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company